UnitedHealthcare · SCS Traditional · US health-plan appeal rights

SCS Traditional denied due to quantity / dose limits by UnitedHealthcare?

Q: How long do I have to appeal a UnitedHealthcare SCS Traditional denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-10

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What UnitedHealthcare typically requires

UnitedHealthcare's specific coverage criteria for scs traditional are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: UHC Commercial: Spinal Cord and Dorsal Root Ganglion Stimulators (mirrors NACC + CMS NCD 160.7)

The UnitedHealthcare angle on SCS Traditional

## Why UnitedHealthcare Denies Traditional Spinal Cord Stimulation for Quantity Limits

Quantity-limit denials for traditional spinal cord stimulation (SCS) from UnitedHealthcare generally arise in one of several contexts: authorization for more than one SCS system within a defined period (for example, a revision or replacement implant); requests for expanded coverage of leads, extensions, or accessories beyond a standard initial implant; or requests for a second trial when the plan has already authorized one. The plan's quantity restrictions are spelled out in its coverage policy, and understanding the exact restriction at issue is essential before crafting your appeal.

## Why This Denial Is Appealable

Quantity limits are not absolute. Plans must allow exceptions when clinical circumstances justify exceeding the standard limit — for example, device failure, lead migration, infection requiring explant and reimplant, inadequate therapeutic response requiring a system upgrade, or changed clinical circumstances that necessitate a different configuration. If your situation involves any of these, the quantity-limit denial can be overturned by documenting the clinical reason the standard limit is insufficient for your case.

## Federal Appeal Framework

Internal appeal (ACA §2719 / ERISA §503): File within the deadline in the denial letter. Your appeal should explain the specific clinical reason that the plan's quantity limit does not apply to your situation or should be excepted.
External review: After a final internal denial, escalate to independent external review. An independent clinical reviewer will evaluate whether the quantity restriction, as applied to your specific clinical circumstances, is medically appropriate.
Expedited review: Available if delay would seriously jeopardize your health — for example, if a failed or infected device requires urgent revision.
State process: For fully insured plans, a complaint to your state insurance commissioner runs in parallel.

## Documentation to Gather

Clinical basis for the additional quantity: Detailed notes from your implanting physician explaining why the prior device, lead, or component is insufficient — covering hardware failure, lead migration, infection, inadequate coverage, or other clinical justification.
Device and procedure history: Prior authorization records, operative reports, and clinical notes documenting the history of your SCS therapy, including dates of prior implants, revisions, or explants.
Imaging or diagnostic support: X-rays, fluoroscopy images, or other imaging showing lead position, migration, fracture, or other hardware issues if applicable.
Manufacturer documentation: If the device has failed, a manufacturer's statement or technical assessment may support the clinical record.
Prescriber letter: A letter from your implanting physician specifically addressing why the plan's quantity limit is clinically inappropriate for your situation and what the consequence of denying additional coverage would be.
Applicable guideline support: Reference to professional society guidance on SCS revision indications.

## Criteria-Mapping Structure

Obtain UHC's current SCS coverage policy and identify the specific quantity-limit language at issue. Your appeal letter should quote the restriction, then present the clinical exception: the specific chart-documented reason your situation falls outside the norm the restriction was designed to address. Present this as a direct, point-by-point rebuttal to the denial rationale.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other UnitedHealthcare appeals

Other insurers on SCS Traditional

Other denial reasons for UnitedHealthcare SCS Traditional

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-10. Editorial standards: denialhelp.com/authors.